154 related articles for article (PubMed ID: 18026149)
1. High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial.
Papadimitriou C; Dafni U; Anagnostopoulos A; Vlachos G; Voulgaris Z; Rodolakis A; Aravantinos G; Bamias A; Bozas G; Kiosses E; Gourgoulis GM; Efstathiou E; Dimopoulos MA
Bone Marrow Transplant; 2008 Mar; 41(6):547-54. PubMed ID: 18026149
[TBL] [Abstract][Full Text] [Related]
2. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
3. Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT.
Möbus V; Wandt H; Frickhofen N; Bengala C; Champion K; Kimmig R; Ostermann H; Hinke A; Ledermann JA; ;
J Clin Oncol; 2007 Sep; 25(27):4187-93. PubMed ID: 17698804
[TBL] [Abstract][Full Text] [Related]
4. Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.
Schmid P; Schippinger W; Nitsch T; Huebner G; Heilmann V; Schultze W; Hausmaninger H; Wischnewsky M; Possinger K
J Clin Oncol; 2005 Jan; 23(3):432-40. PubMed ID: 15659490
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer.
Frickhofen N; Berdel WE; Opri F; Haas R; Schneeweiss A; Sandherr M; Kuhn W; Hossfeld DK; Thomssen C; Heimpel H; Kreienberg R; Hinke A; Möbus V; ;
Bone Marrow Transplant; 2006 Oct; 38(7):493-9. PubMed ID: 16980997
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
[TBL] [Abstract][Full Text] [Related]
7. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
Stemmler HJ; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb HJ
Anticancer Res; 2005; 25(4):3047-54. PubMed ID: 16080564
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution.
Bertucci F; Viens P; Gravis G; Blaise D; Faucher C; Oziel-Taoeb S; Bardou VJ; Jacquemier J; Delpero JR; Maraninchi D
Anticancer Res; 1999; 19(2B):1455-61. PubMed ID: 10365123
[TBL] [Abstract][Full Text] [Related]
10. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
Schlemmer M; Wendtner CM; Falk M; Abdel-Rahman S; Licht T; Baumert J; Straka C; Hentrich M; Salat C; Hiddemann W; Issels RD
Oncology; 2006; 71(1-2):32-9. PubMed ID: 17344669
[TBL] [Abstract][Full Text] [Related]
12. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation.
Donato ML; Aleman A; Champlin RE; Saliba RM; Wharton JT; Burke TW; Bodurka DC; Bevers MW; Levenback CF; Wolf JK; Bast RC; Freedman RS; Ippoliti C; Brewer M; Gajewski JL; Gershenson DM
Bone Marrow Transplant; 2004 Jun; 33(12):1219-24. PubMed ID: 15122311
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results.
Salerno MG; Ferrandina G; Greggi S; Pierelli L; Menichella G; Leone G; Scambia G; Mancuso S
Bone Marrow Transplant; 2001 May; 27(10):1017-25. PubMed ID: 11438815
[TBL] [Abstract][Full Text] [Related]
14. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N
J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705
[TBL] [Abstract][Full Text] [Related]
15. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.
Sanchorawala V; Wright DG; Quillen K; Finn KT; Dember LM; Berk JL; Doros G; Fisher C; Skinner M; Seldin DC
Bone Marrow Transplant; 2007 Sep; 40(6):557-62. PubMed ID: 17589534
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
Jang G; Ko OB; Kim S; Lee DH; Huh J; Suh C
Transfusion; 2008 Apr; 48(4):640-6. PubMed ID: 18194384
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.
Aghajanian C; Fennelly D; Shapiro F; Waltzman R; Almadrones L; O'Flaherty C; O'Conner K; Venkatraman E; Barakat R; Curtin J; Brown C; Reich L; Wuest D; Norton L; Hoskins W; Spriggs DR
J Clin Oncol; 1998 May; 16(5):1852-60. PubMed ID: 9586901
[TBL] [Abstract][Full Text] [Related]
18. High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myeloma.
Bishton M; Gilyead M; Das Gupta E; Williams C; Russell NH; Byrne JL
Leuk Res; 2007 Aug; 31(8):1063-8. PubMed ID: 17324463
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol.
Lotz JP; Curé H; Janvier M; Asselain B; Morvan F; Legros M; Audhuy B; Biron P; Guillemot M; Goubet J; Laadem A; Cailliot C; Maignan CL; Delozier T; Glaisner S; Maraninchi D; Roché H; Gisselbrecht C
Eur J Cancer; 2005 Jan; 41(1):71-80. PubMed ID: 15617992
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy and autologous stem cell transplantation in advanced epithelial ovarian cancer.
Cure H; Legros M; Fleury J; Dauplat J; Condat P; Choufi B; Chollet P; Plagne R
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S34-5. PubMed ID: 8899168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
